3rd Quarter - Report

AMERICAN OSTEOPATHIC ASSOCIATION for AMERICAN OSTEOPATHIC ASSOCIATION

Firm
Client
Income
—
Expenses
$151,995
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

9 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Labor HHS Appropriations

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
RAY QUINTERO Sr. Vice President Public Policy
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Vice President Public Policy

Contacted: Government Accountability Office (GAO); Office of Management & Budget (OMB); SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Executive Office of the President (EOP); Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; White House Office; Centers For Disease Control & Prevention (CDC)

Insurance INS

Health Insurance; Professional Liability Insurance; State Insurance Marketplace

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
RAY QUINTERO Sr. Vice President Public Policy
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Vice President Public Policy

Contacted: Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; White House Office; Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Health Resources & Services Administration (HRSA); Executive Office of the President (EOP); Government Accountability Office (GAO); Centers For Disease Control & Prevention (CDC); SENATE; Agency for Healthcare Research & Quality (AHRQ); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Education EDU

Student Loan Financing and Re-Financing

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
RAY QUINTERO Sr. Vice President Public Policy
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Vice President Public Policy

Contacted: Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Agency for Healthcare Research & Quality (AHRQ); White House Office; SENATE; Government Accountability Office (GAO); Food & Drug Administration (FDA); Medicare Payment Advisory Commission (MedPAC); Executive Office of the President (EOP)

Medical/Disease Research/Clinical Labs MED

NIH; FDA; Agency for Health Care Quality & Research Funding

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
RAY QUINTERO Sr. Vice President Public Policy
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Vice President Public Policy

Contacted: Health Resources & Services Administration (HRSA); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Agency for Healthcare Research & Quality (AHRQ); White House Office; Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); SENATE; Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Government Accountability Office (GAO); Executive Office of the President (EOP)

Torts TOR

Professional Liability Insurance; Medical Liability Reform

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
RAY QUINTERO Sr. Vice President Public Policy
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Vice President Public Policy

Contacted: Food & Drug Administration (FDA); SENATE; Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; White House Office; Agency for Healthcare Research & Quality (AHRQ); Health Resources & Services Administration (HRSA); Medicare Payment Advisory Commission (MedPAC); Government Accountability Office (GAO)

Defense DEF

Recognition of Osteopathic Certification

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
RAY QUINTERO Sr. Vice President Public Policy
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Vice President Public Policy

Contacted: Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Health Resources & Services Administration (HRSA); Executive Office of the President (EOP); SENATE; HOUSE OF REPRESENTATIVES; Government Accountability Office (GAO); White House Office; Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ); Medicare Payment Advisory Commission (MedPAC)

Taxation/Internal Revenue Code TAX

Flexible Spending Accounts; Health Savings Accounts

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
RAY QUINTERO Sr. Vice President Public Policy
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Vice President Public Policy

Contacted: Office of Management & Budget (OMB); Agency for Healthcare Research & Quality (AHRQ); White House Office; Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); SENATE; Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; Government Accountability Office (GAO)

Health Issues HCR

Medicare Physician Payments Reform, Patient access to care; Graduate Medical Education; Physician Workforce Issues; Health reform implementation (PL 111-148); Telehealth (Health Information Technology)

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
RAY QUINTERO Sr. Vice President Public Policy
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Vice President Public Policy

Contacted: Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Executive Office of the President (EOP); Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); SENATE; Government Accountability Office (GAO); HOUSE OF REPRESENTATIVES; Agency for Healthcare Research & Quality (AHRQ); White House Office

Medicare/Medicaid MMM

Graduate Medical Education; Health Care Quality, Patient Access to Health Care; Physician Workforce; Medicare Physician Payment Issues; Independent Payment Advisory Board. H.R. 574, The Medicare Physician Payment Innovation Act of 2013.

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
RAY QUINTERO Sr. Vice President Public Policy
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Vice President Public Policy

Contacted: Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS); SENATE; White House Office; HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Government Accountability Office (GAO); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Office of Management & Budget (OMB); Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); Agency for Healthcare Research & Quality (AHRQ)

Bills named: H.R. 574 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.